Skip to content

A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.

A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.

In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.

In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.

At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.

At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.

Published on

Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

A Stanford physician argues pregnant women should be appropriately included in clinical research to improve their health and the health of their fetuses.

A Stanford physician argues pregnant women should be appropriately included in clinical research to improve their health and the health of their fetuses.

A study confirmed that patients with peripheral artery disease have a higher risk of heart attack, and are more likely to have a rarer type of heart attack.

A study confirmed that patients with peripheral artery disease have a higher risk of heart attack, and are more likely to have a rarer type of heart attack.

Published on

Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.

Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.

Published on

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds

The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds

Published on